Larissa Gomes Dos Reis1, Maree Svolos2, Lyn M Moir2, Rima Jaber3, Norbert Windhab3, Paul M Young2, Daniela Traini2. 1. Respiratory Technology, Woolcock Institute of Medical Research and Discipline of Pharmacology, Sydney Medical School, Sydney University, 431 Glebe Point Road, Glebe, Camperdown, NSW, 2037, Australia. larissa.gomes@sydney.edu.au. 2. Respiratory Technology, Woolcock Institute of Medical Research and Discipline of Pharmacology, Sydney Medical School, Sydney University, 431 Glebe Point Road, Glebe, Camperdown, NSW, 2037, Australia. 3. Evonik Industries AG, Kirschenallee, 64293, Darmstadt, Germany.
Abstract
PURPOSE: In this study, a cell penetrating peptide was used as an uptake enhancer for pDNA delivery to the lungs. METHODS: Polyplexes were prepared between pDNA and CPP. Intracellular delivery of pDNA was assessed in both alveolar (A549) and bronchial (Calu-3) epithelial cells. Aerosol delivery was investigated using a mesh nebulizer. RESULTS: Efficient intracellular delivery of pDNA occurs in both A549 and Calu-3 cells when delivered as polyplexes. Protection against nucleases and endosomal escape mechanism occurs when pDNA is formulated within the polyplexes. For aerosol delivery, 1% (w/v) mannitol was able to protect naked DNA structure during nebulization with a significant increase in fine particle fraction (particles <5 μm). The structure of polyplexes when delivered via a mesh nebulizer using 1% (w/v) mannitol could partially withstand the shear forces involved in aerosolization. Although some loss in functionality occurred after nebulization, membrane-associated fluorescence was observed in A549 cells. In Calu-3 cells mucus entrapment was a limiting factor for polyplex delivery. CONCLUSIONS: The presence of CPP is essential for efficient intracellular delivery of pDNA. The polyplexes can be delivered to lung epithelial cells using mesh nebulizer. The use of different excipients is essential for further optimization of these delivery systems.
PURPOSE: In this study, a cell penetrating peptide was used as an uptake enhancer for pDNA delivery to the lungs. METHODS: Polyplexes were prepared between pDNA and CPP. Intracellular delivery of pDNA was assessed in both alveolar (A549) and bronchial (Calu-3) epithelial cells. Aerosol delivery was investigated using a mesh nebulizer. RESULTS: Efficient intracellular delivery of pDNA occurs in both A549 and Calu-3 cells when delivered as polyplexes. Protection against nucleases and endosomal escape mechanism occurs when pDNA is formulated within the polyplexes. For aerosol delivery, 1% (w/v) mannitol was able to protect naked DNA structure during nebulization with a significant increase in fine particle fraction (particles <5 μm). The structure of polyplexes when delivered via a mesh nebulizer using 1% (w/v) mannitol could partially withstand the shear forces involved in aerosolization. Although some loss in functionality occurred after nebulization, membrane-associated fluorescence was observed in A549 cells. In Calu-3 cells mucus entrapment was a limiting factor for polyplex delivery. CONCLUSIONS: The presence of CPP is essential for efficient intracellular delivery of pDNA. The polyplexes can be delivered to lung epithelial cells using mesh nebulizer. The use of different excipients is essential for further optimization of these delivery systems.
Authors: Lee A Davies; Kevin Hannavy; Neville Davies; Alistair Pirrie; Ronald A Coffee; Stephen C Hyde; Deborah R Gill Journal: Pharm Res Date: 2005-08-03 Impact factor: 4.200
Authors: Emerson R Silva; Gary Cooney; Ian W Hamley; Wendel A Alves; Shannon Lee; Brendan F O'Connor; Mehedi Reza; Janne Ruokolainen; Dermot Walls Journal: Soft Matter Date: 2016-11-16 Impact factor: 3.679
Authors: Lee A Davies; Graciela A Nunez-Alonso; Gerry McLachlan; Stephen C Hyde; Deborah R Gill Journal: Hum Gene Ther Clin Dev Date: 2014-05-27 Impact factor: 5.032
Authors: Marjo Männistö; Mika Reinisalo; Marika Ruponen; Paavo Honkakoski; Markku Tammi; Arto Urtti Journal: J Gene Med Date: 2007-06 Impact factor: 4.565
Authors: Rike Wallbrecher; Wouter P R Verdurmen; Samuel Schmidt; Petra H Bovee-Geurts; Felix Broecker; Anika Reinhardt; Toin H van Kuppevelt; Peter H Seeberger; Roland Brock Journal: Cell Mol Life Sci Date: 2013-11-24 Impact factor: 9.261